Groww Logo
Home>IPO>Krishna Institute of Medical Sciences Limited IPO

KIMS IPO

Krishna Institute of Medical Sciences Limited IPO

₹14,670 /18 sharesMinimum Investment

KIMS IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
16 Jun '21 - 18 Jun '21₹14,67018₹815 - ₹825
Issue SizeIPO Doc
2143.74Cr
RHP PDF

Subscription Status As on 18 Jun '21, 4:50 PM

  • Retail Individual Investor
    2.89x
  • Non-Institutional Investor
    1.89x
  • Qualified Institutional Buyers
    5.26x
  • Employees
    1.06x

About KIMS

Krishna Institute of Medical Sciences Ltd. is one of the largest corporate healthcare groups in Andhra Pradesh and Telan

Strengths & Risks

  • One of the largest corporate healthcare groups in Telangana and Andhra Pradesh.
  • Well-positioned to consolidate in India’s large, unorganized yet rapidly growing and underserved affordable healthcare market.
  • Ability to attract, train and retain high-quality doctors, consultants, and medical support staff.
  • Track record of strong operational and financial performance.
  • Successful history of sourcing, executing and integrating acquisitions.
  • Experienced senior management team with strong institutional shareholder support.
  • Dependence on its healthcare professionals, including doctors that KIMS engages on a consultancy basis.
  • COVID-19 pandemic and other health concerns that may impact regular business operations.
  • Dependence on hospitals in Hyderabad and certain specialties.
  • Hospitals built on leased land and inability to renew the lease for any reason.
  • Impact of short-term and long-term borrowings.
  • Inability to comply with applicable safety, health, environmental, and other governmental regulations.
  • Inability to effectively estimate, price, and manage its healthcare costs can affect operations.
  • Inability to maintain bed occupancy rates at sufficient levels may impact business.
  • Inability to keep pace with technological changes, new equipment & service introductions, changes in patients' needs, and evolving industry standards.
  • Dependence on payments from patients, insurers, and other payers.
  • Risk of legal claims and regulatory actions arising out of the medical services provided by KIMS.
  • Failure of third-party suppliers and manufacturers to provide supplies and equipment on time.
  • Risks relating to the handling of personal information, including medical data.

Financials

*All values are in Rs. Cr
No Graph Data To Display
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 2.3.7
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI

ABOUT GROWW